TABLE 3.
Time period |
||||
Treatment | 3 wk | 6 wk | 9 wk | 12 wk |
∆ Squat 1-RM, kg | ||||
PB | 20 (–0.3, 40) | 42 (21, 62) | 61 (41, 82) | 90 (69, 110) |
WP | 26 (5, 47) | 41 (20, 62) | 60 (38, 82) | 100 (80, 120) |
MDP | 19 (–2, 39) | 41 (20, 62) | 62 (41, 83) | 94.0 (72, 120) |
∆ Knee extension, kg | ||||
PB | 17 (6, 29) | 32 (20, 43) | 46 (34, 57) | 62 (50, 74) |
WP | 21 (9, 33) | 39 (27, 51) | 51 (39, 63) | 64 (51, 77) |
MDP | 19 (7, 30) | 31 (19, 43) | 42 (29, 54) | 64 (52, 77) |
∆ Chest press, kg | ||||
PB | 13 (6, 19) | 21 (14, 27) | 27 (20, 33) | 36 (30, 43) |
WP | 14 (7, 20) | 22 (16, 29) | 28 (21, 35) | 34 (27, 41) |
MDP | 12 (6, 19) | 21 (14, 28) | 29 (22, 36) | 38 (31, 45) |
∆ Mean of all exercises,2 kg | ||||
PB | 13 (6, 19) | 22 (15, 28) | 31 (25, 37) | 41 (34, 47) |
WP | 14 (8, 21) | 23 (17, 30) | 33 (26, 40) | 47 (40, 54) |
MDP | 13 (6, 19) | 22 (16, 28) | 31 (24, 37) | 43 (37, 50) |
Values are means (95% CIs). Sample sizes/group at 3, 6, 9, and 12 wk, respectively—MDP: n = 20, 17, 16, and 16; PB: n = 23, 23, 23, and 22; and WP: n = 20, 20, 19, and 18. MDP, maltodextrin placebo; PB, soy-dairy protein blend; WP, whey protein; 1-RM, 1 repetition maximum; ∆, change.
The mean represents the mean 1-RM increase from all of the exercises used in training.